Klotho Neurosciences is rebranding to Greenland Mines Ltd with a new ticker symbol GRML effective March 12, 2026, following its acquisition of Greenland Mines Corp. The company is pivoting from neuroscience to natural resources, focusing on the Skaergaard Project in Southeast Greenland, one of the world's largest undeveloped palladium, gold, and ...

Klotho Neurosciences (NASDAQ: KLTO) announced the acquisition of Greenland Mines Corp, which controls an 80% interest in the Skaergaard Project in Southeast Greenland. The project hosts significant palladium, gold, and platinum deposits valued at approximately $68 billion. Post-closing, the company will operate under two divisions: Natural Resour...

Klotho Neurosciences (NASDAQ: KLTO) announced the acquisition of Greenland Mines Corp, which controls an 80% interest in the Skaergaard Project in Southeast Greenland. The project hosts significant palladium, gold, and platinum deposits valued at approximately $68 billion. Post-closing, the company will operate under two divisions: Natural Resour...

Klotho Neurosciences has partnered with AAVnerGene to enhance gene therapy manufacturing processes for neurological disease treatments, focusing on more efficient and cost-effective AAV vector technologies.

Klotho Neurosciences regained full compliance with Nasdaq listing requirements and will remain listed on the stock market. The company recently received FDA Orphan Drug Designation for its ALS therapy candidate and has seen significant stock price growth.